Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00636779 · ClinicalTrials.gov registry record
BraveNet Integrative Medicine Descriptive Study
A clinical trial of Healthy, sponsored by Duke University.
- Completed
- Registry status
- 4,340
- Enrollment target
- 8
- Study locations
NCT00636779: Completed study of Healthy, sponsored by Duke University.
NCT00636779 is a study of Healthy that has completed, run by Duke University. The registered enrollment target is 4,340 participants, above the 643-participant average among 1,090 other Healthy trials with a reported enrollment target (575% higher). The trial reports 8 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00636779, a study of Healthy, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 4,340 participants
- Enrollment target
- 8
- Study locations
Study Summary
The Bravewell Integrative Medicine Research Network (BraveNet) is a newly formed practice-based research network of nine leading integrative medicine centers around the U.S. collaborating in clinical outcomes research to increase the knowledge and evidence-base of integrative medicine.
Conditions Studied
Study Locations (8)
California
- Scripps Center for Integrative Medicine - La Jolla
- Osher Center for Integrative Medicine - San Francisco
- Venice Family Clinic - Santa Monica
Maryland
- University of Maryland Center for Integrative Medicine - Baltimore
Minnesota
- Penny George Institute for Health and Healing - Minneapolis
North Carolina
- Duke Integrative Medicine - Durham
Ohio
- Alliance Center for Integrative Medicine - Cincinnati
Pennsylvania
- Jefferson-Myrna Brind Center of Integrative Medicine - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,340 participants |
| Start Date | 2008-03 |
| Est. Completion | 2011-06 |
What the finished NCT00636779 record still lists
NCT00636779 is an observational study that tracks outcomes without assigning an intervention. Its 4,340 participants enrollment target places it among the larger protocols in the corpus, above the 643-participant average among 1,090 other Healthy trials with a reported enrollment target (575% higher).
The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 0 interventions.
NCT00636779 lists 8 locations in 6 states (California, Maryland, Minnesota).
Frequently Asked Questions
What is clinical trial NCT00636779 about?
NCT00636779 is a clinical study titled "BraveNet Integrative Medicine Descriptive Study". The Bravewell Integrative Medicine Research Network (BraveNet) is a newly formed practice-based research network of nine leading integrative medicine centers around the U.S. collaborating in clinical outcomes research to increase the knowledge and evidence-base of integrative medicine.
What is the current status of trial NCT00636779?
This trial is currently completed. The enrollment target is 4,340 participants. The study started on 2008-03. Estimated completion is 2011-06.
What conditions does trial NCT00636779 study?
This clinical trial studies the following conditions: Healthy.
Who is sponsoring clinical trial NCT00636779?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00636779 being conducted?
This trial has 8 study locations across California, Maryland, Minnesota, North Carolina, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00636779's enrollment target sits among peer trials
4,340 15th of 1090 higher than 1,076 of 1,090 other Healthy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mapping Auricular Vagus Nerve Circuitry
RECRUITING · Early Phase 1
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
A Study of LY3867070 in Healthy Participants
RECRUITING · Phase 1
-
The Modulatory Effect of Female Sex Hormones on Spinal Neuroplasticity
RECRUITING
-
Breathing & Blood Pressure
RECRUITING
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05910567 · 4,346 participants · NA
A Research Study of Abdominal Ultrasound (FAST) in Children With Blunt Torso Trauma
- NCT05774951 · 4,300 participants · Phase 3
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
- NCT05543616 · 4,292 participants · Phase 2
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children
- NCT07044297 · 4,390 participants · Phase 3
A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia